Cargando…

Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments

Chitosan (CS) is a hemi-synthetic cationic linear polysaccharide produced by the deacetylation of chitin. CS is non-toxic, highly biocompatible, and biodegradable, and it has a low immunogenicity. Additionally, CS has inherent antibacterial properties and a mucoadhesive character and can disrupt epi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamboulis, Alexandra, Nanaki, Stavroula, Michailidou, Georgia, Koumentakou, Ioanna, Lazaridou, Maria, Ainali, Nina Maria, Xanthopoulou, Eleftheria, Bikiaris, Dimitrios N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407599/
https://www.ncbi.nlm.nih.gov/pubmed/32650536
http://dx.doi.org/10.3390/polym12071519
_version_ 1783567660009652224
author Zamboulis, Alexandra
Nanaki, Stavroula
Michailidou, Georgia
Koumentakou, Ioanna
Lazaridou, Maria
Ainali, Nina Maria
Xanthopoulou, Eleftheria
Bikiaris, Dimitrios N.
author_facet Zamboulis, Alexandra
Nanaki, Stavroula
Michailidou, Georgia
Koumentakou, Ioanna
Lazaridou, Maria
Ainali, Nina Maria
Xanthopoulou, Eleftheria
Bikiaris, Dimitrios N.
author_sort Zamboulis, Alexandra
collection PubMed
description Chitosan (CS) is a hemi-synthetic cationic linear polysaccharide produced by the deacetylation of chitin. CS is non-toxic, highly biocompatible, and biodegradable, and it has a low immunogenicity. Additionally, CS has inherent antibacterial properties and a mucoadhesive character and can disrupt epithelial tight junctions, thus acting as a permeability enhancer. As such, CS and its derivatives are well-suited for the challenging field of ocular drug delivery. In the present review article, we will discuss the properties of CS that contribute to its successful application in ocular delivery before reviewing the latest advances in the use of CS for the development of novel ophthalmic delivery systems. Colloidal nanocarriers (nanoparticles, micelles, liposomes) will be presented, followed by CS gels and lenses and ocular inserts. Finally, instances of CS coatings, aiming at conferring mucoadhesiveness to other matrixes, will be presented.
format Online
Article
Text
id pubmed-7407599
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74075992020-08-25 Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments Zamboulis, Alexandra Nanaki, Stavroula Michailidou, Georgia Koumentakou, Ioanna Lazaridou, Maria Ainali, Nina Maria Xanthopoulou, Eleftheria Bikiaris, Dimitrios N. Polymers (Basel) Review Chitosan (CS) is a hemi-synthetic cationic linear polysaccharide produced by the deacetylation of chitin. CS is non-toxic, highly biocompatible, and biodegradable, and it has a low immunogenicity. Additionally, CS has inherent antibacterial properties and a mucoadhesive character and can disrupt epithelial tight junctions, thus acting as a permeability enhancer. As such, CS and its derivatives are well-suited for the challenging field of ocular drug delivery. In the present review article, we will discuss the properties of CS that contribute to its successful application in ocular delivery before reviewing the latest advances in the use of CS for the development of novel ophthalmic delivery systems. Colloidal nanocarriers (nanoparticles, micelles, liposomes) will be presented, followed by CS gels and lenses and ocular inserts. Finally, instances of CS coatings, aiming at conferring mucoadhesiveness to other matrixes, will be presented. MDPI 2020-07-08 /pmc/articles/PMC7407599/ /pubmed/32650536 http://dx.doi.org/10.3390/polym12071519 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Zamboulis, Alexandra
Nanaki, Stavroula
Michailidou, Georgia
Koumentakou, Ioanna
Lazaridou, Maria
Ainali, Nina Maria
Xanthopoulou, Eleftheria
Bikiaris, Dimitrios N.
Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments
title Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments
title_full Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments
title_fullStr Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments
title_full_unstemmed Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments
title_short Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments
title_sort chitosan and its derivatives for ocular delivery formulations: recent advances and developments
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407599/
https://www.ncbi.nlm.nih.gov/pubmed/32650536
http://dx.doi.org/10.3390/polym12071519
work_keys_str_mv AT zamboulisalexandra chitosananditsderivativesforoculardeliveryformulationsrecentadvancesanddevelopments
AT nanakistavroula chitosananditsderivativesforoculardeliveryformulationsrecentadvancesanddevelopments
AT michailidougeorgia chitosananditsderivativesforoculardeliveryformulationsrecentadvancesanddevelopments
AT koumentakouioanna chitosananditsderivativesforoculardeliveryformulationsrecentadvancesanddevelopments
AT lazaridoumaria chitosananditsderivativesforoculardeliveryformulationsrecentadvancesanddevelopments
AT ainalininamaria chitosananditsderivativesforoculardeliveryformulationsrecentadvancesanddevelopments
AT xanthopouloueleftheria chitosananditsderivativesforoculardeliveryformulationsrecentadvancesanddevelopments
AT bikiarisdimitriosn chitosananditsderivativesforoculardeliveryformulationsrecentadvancesanddevelopments